EMRUSOLMIN

Welcome to the Brand page for “EMRUSOLMIN”, which is offered here for Medicines for human purposes; medicines for veterinary purposes; pharmaceuticals and natural remedies; medicines for the treatment of alzheimer's disease; medicines for the treatment of neurodegenerative diseases; medicines for the treatment of cardiovascular and cerebrovascular diseases; chemico-pharmaceutical preparations; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; diagnostic preparations and materials; diagnostic biomarker reagents for medical purposes; diagnostic reagents for medical use; dragees; injectable pharmaceuticals; medicinal preparations and substances; antiparkinson agents; pharmaceutical drugs; pharmaceuticals; pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of parkinson's disease; pharmaceutical preparations for the treatment of alzeimer's disease; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of cerebral disease; pharmaceutical preparations for the treatment of central nervous system diseases;medication counseling; providing information to patients in the field of administering medications; provision of information relating to pharmaceutical products; provision of information relating to the treatment of degenerative diseases; provision of information relating to medical services; provision of pharmaceutical information; advisory services relating to the treatment of degenerative diseases; consultancy and information services relating to pharmaceutical products; consultancy and information services provided via the internet relating to pharmaceutical products; consultancy and information services relating to medical products; advisory services relating to medicines; medical services; medical services for treating alzheimer's disease; pharmaceutical services; preparation and dispensing of medications;providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to pharmaceutical research and development; biological research, clinical research and medical research; medical research laboratory services; testing of pharmaceuticals; analysis of human serum for medical research; analysis of human tissues for medical research; development of pharmaceutical preparations and medicines; pharmaceutical products development; research and development of vaccines and medicines; providing scientific information in the field of medical disorders and their treatment; research in the field of pharmacogenetics; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; clinical research; laboratory research services relating to pharmaceuticals; medical research; medical and pharmacological research services; pharmaceutical drug development services; pharmaceutical research services; pharmaceutical research and development; inspection of pharmaceuticals; scientific research in the field of pharmacy; scientific research and development;.

Its status is currently believed to be active. Its class is unavailable. “EMRUSOLMIN” is believed to be currently owned by “MODAG GmbH”.